PEPCID AC Drug Patent Profile
✉ Email this page to a colleague
When do Pepcid Ac patents expire, and what generic alternatives are available?
Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs.
The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and forty-four suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Ac
A generic version of PEPCID AC was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEPCID AC?
- What are the global sales for PEPCID AC?
- What is Average Wholesale Price for PEPCID AC?
Summary for PEPCID AC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 35 |
Patent Applications: | 7,161 |
What excipients (inactive ingredients) are in PEPCID AC? | PEPCID AC excipients list |
DailyMed Link: | PEPCID AC at DailyMed |
Recent Clinical Trials for PEPCID AC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University Comprehensive Cancer Center | Phase 2/Phase 3 |
Leidos Life Sciences | Phase 2 |
United States Department of Defense | Phase 2 |
Pharmacology for PEPCID AC
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |
US Patents and Regulatory Information for PEPCID AC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID AC | famotidine | TABLET, CHEWABLE;ORAL | 020801-001 | Sep 24, 1998 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET, CHEWABLE;ORAL | 020801-002 | Dec 17, 2007 | OTC | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEPCID AC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | ⤷ Subscribe | ⤷ Subscribe |
J And J Consumer Inc | PEPCID AC | famotidine | TABLET, CHEWABLE;ORAL | 020801-002 | Dec 17, 2007 | ⤷ Subscribe | ⤷ Subscribe |
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-001 | Apr 28, 1995 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEPCID AC
See the table below for patents covering PEPCID AC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 69109163 | ⤷ Subscribe | |
Portugal | 96837 | DISPOSITIVO E PROCESSO PARA A PREPARACAO DE MEDICAMENTOS REVESTIDOS APERFEICOADOS | ⤷ Subscribe |
Denmark | 157132 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
PEPCID AC Market Analysis and Financial Projection Experimental
More… ↓